GlobalData Market Research Reports





RSS Sort By :
TITLE Price Buy Now More options

GlobalData's clinical trial report, Strabismus Global Clinical Trials Review, H1, 2013 provides data on the Strabismus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on ...

$ 2500


GlobalData's clinical trial report, Reperfusion Injury Global Clinical Trials Review, H1, 2013 provides data on the Reperfusion Injury clinical trial scenario. This report provides elemental information and data relating to the cli...

$ 2500


GlobalData's clinical trial report, Ulcers Global Clinical Trials Review, H1, 2013 provides data on the Ulcers clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ulcers. ...

$ 2500


GlobalData's clinical trial report, Hypotension Global Clinical Trials Review, H1, 2013 provides data on the Hypotension clinical trial scenario. This report provides elemental information and data relating to the clinical trials o...

$ 2500


GlobalData's clinical trial report, Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2013 provides data on the Hidradenitis Suppurativa clinical trial scenario. This report provides elemental information and data relatin...

$ 2500


GlobalData's clinical trial report, Ocular Hypertension Global Clinical Trials Review, H1, 2013 provides data on the Ocular Hypertension clinical trial scenario. This report provides elemental information and data relating to the c...

$ 2500


GlobalData's clinical trial report, Deglutition Disorders Global Clinical Trials Review, H1, 2013 provides data on the Deglutition Disorders clinical trial scenario. This report provides elemental information and data relating to t...

$ 2500


Industry analysis specialist GlobalData has released its new report, Healthcare, Regulatory and Reimbursement Landscape - Thailand. An essential source of information and analysis on the Thai healthcare, regulatory and reimbursement la...

$ 1995


GlobalData, the industry analysis specialist, has released its new report, Healthcare, Regulatory and Reimbursement Landscape - New Zealand. The report is an essential source of information and analysis on New Zealand`s healthcare, reg...

$ 1995


GlobalData's new report Haynesville Shale in the US, 2012 Gas Shale Market Analysis and Forecasts to 2020 provides insight into the exploration and development activities in the Haynesville shale play. The report highli...

$ 1500


GlobalData’s energy offering, Refining Industry Outlook in Europe, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017” is the essential source for industry data and information relati...

$ 5000


GlobalData’s energy offering, Refining Industry Outlook in South and Central America, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017” is the essential source for industry data and...

$ 5000


GlobalData has released its new Country report, PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily...

$ 4995


PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characteri

$ 4995


GlobalData has released its new Country report, PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is he...

$ 4995


GlobalData has released its new Country report, PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heav...

$ 4995


PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterize

$ 4995


PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by s

$ 4995


PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterize

$ 4995


PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterize

$ 4995

Live Chat Support
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest from GlobalData. We have market research reports of all sectors covered by the GlobalData; you can access and utilize them at economical budgets.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100